VERSANISBIO.COM: Keyword Density Checker

Total words: 2076 | 2-word phrases: 563 | 3-word phrases: 591 | 4-word phrases: 602

PAGE INFO

Title	Try to keep the title under 60 characters (47 characters) Versanis \| Subsidiaries \| Eli Lilly and Company
Description	Try to keep the meta description between 50 - 160 characters (153 characters) Versanis is a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	expand mega menu	5	0.85%
2	mega menu expand	4	0.68%
3	menu expand submenu	4	0.68%
4	expand submenu collapse	3	0.51%
5	people living with	3	0.51%
6	use privacy statement	2	0.34%
7	fat and muscle	2	0.34%
8	your privacy choices	2	0.34%
9	lilly and team	2	0.34%
10	of use privacy	2	0.34%
11	statement consumer health	2	0.34%
12	investors contact globe	2	0.34%
13	careers investors contact	2	0.34%
14	notice accessibility statement	2	0.34%
15	accessibility statement sitemap	2	0.34%
16	privacy statement consumer	2	0.34%
17	terms of use	2	0.34%
18	subsidiaries partners careers	2	0.34%
19	living with obesity	2	0.34%
20	partners careers investors	2	0.34%
21	in both fat	1	0.17%
22	found in both	1	0.17%
23	both fat and	1	0.17%
24	activin receptors found	1	0.17%
25	the activin receptors	1	0.17%
26	actrii the activin	1	0.17%
27	receptors actrii the	1	0.17%
28	receptors found in	1	0.17%
29	accessibility statement skip	1	0.17%
30	activin type ii	1	0.17%

#	Keyword	Frequency	Density
1	expand mega menu expand	4	0.66%
2	mega menu expand submenu	4	0.66%
3	menu expand submenu collapse	2	0.33%
4	notice accessibility statement sitemap	2	0.33%
5	privacy statement consumer health	2	0.33%
6	use privacy statement consumer	2	0.33%
7	of use privacy statement	2	0.33%
8	terms of use privacy	2	0.33%
9	subsidiaries partners careers investors	2	0.33%
10	partners careers investors contact	2	0.33%
11	careers investors contact globe	2	0.33%
12	people living with obesity	2	0.33%
13	first company to tackle	1	0.17%
14	in obesity versanis is	1	0.17%
15	the first company to	1	0.17%
16	accessibility statement skip to	1	0.17%
17	company to tackle obesity	1	0.17%
18	to tackle obesity by	1	0.17%
19	a role in obesity	1	0.17%
20	tackle obesity by targeting	1	0.17%
21	role in obesity versanis	1	0.17%
22	the body plays a	1	0.17%
23	plays a role in	1	0.17%
24	body plays a role	1	0.17%
25	in the body plays	1	0.17%
26	pathway in the body	1	0.17%
27	activin pathway in the	1	0.17%
28	the activin pathway in	1	0.17%
29	signaling genetic studies suggest	1	0.17%
30	activin signaling genetic studies	1	0.17%
31	and activin signaling genetic	1	0.17%
32	factors and activin signaling	1	0.17%
33	growth factors and activin	1	0.17%
34	exercise growth factors and	1	0.17%
35	combination of nutrient intake	1	0.17%
36	the combination of nutrient	1	0.17%
37	by the combination of	1	0.17%
38	obesity by targeting activin	1	0.17%
39	actrii the activin receptors	1	0.17%
40	by targeting activin type	1	0.17%

#	URL	Whois	Check
1	https://esg.lilly.com/?utm_source=lilly.com&utm_medium=referral&utm_campaign=referral_lilly.com	Whois	lilly.com
2	https://e.lilly/2DfZjg1	Whois	e.lilly
3	https://e.lilly/2NcatuX	Whois	e.lilly
4	https://trials.lilly.com/en-US/	Whois	lilly.com
5	https://e.lilly/2yhbjiw	Whois	e.lilly
6	https://esg.lilly.com	Whois	lilly.com
7	http://lilly.mediaroom.com/	Whois	mediaroom.com
8	https://esg.lilly.com/?utm_source=lilly.com&utm_medium=referral&utm_campaign=referral_lilly.com	Whois	lilly.com
9	https://e.lilly/2DfZjg1	Whois	e.lilly
10	https://e.lilly/2NcatuX	Whois	e.lilly
11	https://www.lilly.com/disease-areas/obesity	Whois	lilly.com
12	https://www.lilly.com/subsidiaries/versanis/privacy-policy-for-clinical-trial-participants/	Whois	lilly.com
13	https://e.lilly/32DJeOl	Whois	e.lilly
14	http://lilly.com	Whois	lilly.com